John Gordon

Colleges, School and Institutes

View graph of relations

Most downloaded publications

Inosine Acedoben Dimepranol promotes an early and sustained increase in the natural killer cell component of circulating lymphocytes: a clinical trial supporting anti-viral indications
Amy Newman, Gillian Grafton, John Curnow, Nicholas Barnes & John Gordon, Jan 2017, In : International Immunopharmacology. 42, p. 108-114

Research output: Contribution to journal › Article

1193 downloads
Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine ('ecstasy') through iterative chemical redesign: mechanisms and pathways to cell death
Michelle Holder, Anita Chamba, Stephen Young, Dagmar Scheel-Toellner, John Gordon, Nicholas Barnes, 18 Aug 2011, In : Investigational New Drugs.

Research output: Contribution to journal › Article

119 downloads

Recent publications

Inosine Acedoben Dimepranol promotes an early and sustained increase in the natural killer cell component of circulating lymphocytes: a clinical trial supporting anti-viral indications
Amy Newman, Gillian Grafton, John Curnow, Nicholas Barnes & John Gordon, Jan 2017, In : International Immunopharmacology. 42, p. 108-114

Research output: Contribution to journal › Article

5-Chloroindole: a potent allosteric modulator of the 5-HT3 receptor: Allosteric modulation of the 5-HT3receptor
Amy Newman, Nikos Batis, Gillian Grafton, John Gordon, Keith Brain, Andrew Powell & Nicholas Barnes, Jul 2013, In : British Journal of Pharmacology. 169, 6, p. 1228-1238 11 p.

Research output: Contribution to journal › Article

ANCA-stimulated neutrophils release BLyS and promote B cell survival: a clinically relevant cellular process.
Neil Holden, Julie Williams, Matthew Morgan, John Gordon, Lorraine Harper & Caroline Savage, 1 Dec 2011, In : Annals of the Rheumatic Diseases. 70, 12, p. 2229-33 5 p.

Research output: Contribution to journal › Article

View all (63)